Tumor-derived SHH activates the Hh-Gli1-Klf4 signaling axis in TAMs, leading to reduced production of CXCL9 and CXCL10, chemokines essential for CD8+ T cell infiltration into the TME [158]. Here, CD8A is linked to neoplasm.